Frankfurt - Delayed Quote EUR

Ramsay Health Care Limited (RMY.F)

20.20
+0.20
+(1.00%)
At close: May 23 at 8:02:15 AM GMT+2
Loading Chart for RMY.F
  • Previous Close 20.00
  • Open 20.20
  • Bid 20.40 x 30000
  • Ask 21.00 x 30000
  • Day's Range 20.20 - 20.20
  • 52 Week Range 17.40 - 30.20
  • Volume 40
  • Avg. Volume 0
  • Market Cap (intraday) 4.738B
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 505.00
  • EPS (TTM) 0.04
  • Earnings Date Feb 26, 2025
  • Forward Dividend & Yield 0.47 (2.32%)
  • Ex-Dividend Date Mar 6, 2025
  • 1y Target Est --

Ramsay Health Care Limited owns and operates hospitals in Australia, and internationally. The company offers health care services to public and private patients. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.

www.ramsayhealth.com

90,000

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RMY.F

View More

Performance Overview: RMY.F

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

RMY.F
3.06%
S&P/ASX 200 [XJO] (^AXJO)
2.47%

1-Year Return

RMY.F
29.68%
S&P/ASX 200 [XJO] (^AXJO)
7.03%

3-Year Return

RMY.F
58.36%
S&P/ASX 200 [XJO] (^AXJO)
16.95%

5-Year Return

RMY.F
42.74%
S&P/ASX 200 [XJO] (^AXJO)
52.10%

Compare To: RMY.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RMY.F

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    4.74B

  • Enterprise Value

    11.08B

  • Trailing P/E

    459.95

  • Forward P/E

    24.51

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.48

  • Price/Book (mrq)

    1.80

  • Enterprise Value/Revenue

    1.15

  • Enterprise Value/EBITDA

    14.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.15%

  • Return on Assets (ttm)

    2.89%

  • Return on Equity (ttm)

    0.52%

  • Revenue (ttm)

    17.12B

  • Net Income Avi to Common (ttm)

    8M

  • Diluted EPS (ttm)

    0.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    342.7M

  • Total Debt/Equity (mrq)

    207.51%

  • Levered Free Cash Flow (ttm)

    616.15M

Research Analysis: RMY.F

View More

Company Insights: RMY.F

Research Reports: RMY.F

View More

People Also Watch